Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Could nan1-expression and production by pseudomonas aeruginosa be a prognostic factor for survival in CF patients

Guergana Petrova, Penka Perenovska, Tanya Strateva
European Respiratory Journal 2016 48: PA4862; DOI: 10.1183/13993003.congress-2016.PA4862
Guergana Petrova
1Pediatric Clinic, University Hospital “Alexandrovska”, Sofia, Bulgaria
2Pediatric Departement, Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Penka Perenovska
1Pediatric Clinic, University Hospital “Alexandrovska”, Sofia, Bulgaria
2Pediatric Departement, Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanya Strateva
3Department of Medical Microbiology, Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Background:  Neuraminidase production in isolates of  Pseudomonas aeruginosa  from CF patients was described and suggested to contribute to pulmonary infection.

Aim: To evaluate nan1 presence in chronically infected with P.aerugenosa CF patients and it's impact on survival and clinical course.

Material and methods: In 2008 we evaluated clinical course and state of 29 patients with cystic fibrosis (CF) aged from 7 to 17 years of age, with chronic P. aeruginosa infection. We searched for nan1 among the studied isolates of P. aeruginosa by PCR. Based on nan1 results the patients were divided in two groups – nan1 positive (nan1 (+)) and nan1 negative (nan1(-)). We reevaluated the same patients 7 years later.

Results: In 2008 there was no significant difference in sex (p>0.05) or genetic mutation (p>0.05) distribution in both groups. Patients' age also was not significantly different 14.3 ± 3.01 years in nan1(+) group (n=14) and 14.0 ± 3.1 years for nan1 (-) (n=15) (p>0.05). Period of chronic colonization was higher in nan1(+) group 5.6 ± 1.4 years vs. 3 ± 1.4 years (p=0.05) . Nan 1(+) group have more recurrent exacerbations of pulmonary disease and weaker clinical status. In 2015 all but one patient from nan1(+) group have died, while in nan1(-) group only 2 death are registered. In 2015 - four from the alive patients from nan1(-) group in 2008 have nan1(+) P.aeruginosa in their sputum, and are in worse clinical (examination and PFT) state compared to the rest 9 of this group, but similar to the only one survival from nan1(+) group.

Conclusion: Chronic pseudomonas infection with strains positive for neuraminidase could be additional prognostic factor for poor prognosis.

  • Bacteria
  • Epidemiology
  • Infections
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Could nan1-expression and production by pseudomonas aeruginosa be a prognostic factor for survival in CF patients
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Could nan1-expression and production by pseudomonas aeruginosa be a prognostic factor for survival in CF patients
Guergana Petrova, Penka Perenovska, Tanya Strateva
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4862; DOI: 10.1183/13993003.congress-2016.PA4862

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Could nan1-expression and production by pseudomonas aeruginosa be a prognostic factor for survival in CF patients
Guergana Petrova, Penka Perenovska, Tanya Strateva
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4862; DOI: 10.1183/13993003.congress-2016.PA4862
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Human neutrophils release bioactive inflammasome complexes; relevance for cystic fibrosis
  • Efficacy and safety of inhaled antibiotics for chronic pseudomonas infection in cystic fibrosis: Network meta-analysis
  • Infant lung function testing: First in vivo report of a novel inert gas washout method to measure LCI
Show more 7.3 Cystic Fibrosis

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society